Back to search

University of British Columbia

Cervical cancer screening and rates of HPV vaccination among women and people with a cervix living with HIV in Canada

Abstract

dc:description

Cervical cancer, caused by Human Papillomavirus (HPV) infection, is one of the most common gynecologic cancers. Cervical cancer is preventable through vaccination, routine screening, and follow-up of abnormal screening results. Women and people with a cervix living with HIV (women with HIV) experience higher rates of persistent HPV infection and cervical cancer, yet, in Canada, rates of vaccine uptake within this population remain largely unknown. Moreover, women with HIV are less likely to participate in cervix screening due to higher rates of discrimination, trauma, and HIV stigma. HPV testing with the option of self-sampling has been implemented in select provinces in Canada. HPV testing is a highly sensitive screening method, and can be self-collected by patients, mitigating many barriers to screening; however, understanding how this screening method impacts referrals to colposcopy and further follow-up procedures remains underexplored. In the context of unknown HPV vaccination rates and very limited screening program data, the aims of this thesis are to determine rates of HPV vaccination and the acceptability of HPV self-sampling among women with HIV in Canada, in the context of a reduced-dosing trial of the nonavalent HPV vaccine. Additionally, this thesis aims to investigate HPV prevalence and estimates for colposcopy referrals according to the BC Cervix screening algorithm among a cohort of women with HIV from a prospective vaccine immunogenicity study. Among five study sites located across Canada, vaccination rates among women with HIV were low (47.2%). Regarding women with HIV’s acceptability of HPV self-sampling, among a cohort of 117 women with HIV, 82.1% agreed that they would use HPV self-sampling for future cervix screening. Many participants were concerned about the implications of receiving a positive HPV result. Almost half (47.2%) of participants had oncogenic HPV detected at study entry, and 15.9% of participants had oncogenic HPV detected each year for three years, which would have resulted in three consecutive referrals to colposcopy. Our data suggest that more efforts are needed to increase HPV vaccine access and uptake among women with HIV in Canada, and to provide education and support around HPV self-sampling and follow-up procedures of screen-positive women with HIV.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Women+ and Children’s Health Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Nicolls, Sofia
Contributors dc:contributor
  • Money, Deborah M.
  • McClymon, Elisabeth

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/93942

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Nicolls, Sofia. Cervical cancer screening and rates of HPV vaccination among women and people with a cervix living with HIV in Canada. master's thesis, University of British Columbia, 2026. http://hdl.handle.net/2429/93942